Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early vs late intralesional dexamethasone injection for supratip polybeak deformity after rhinoplasty
IRCT20120215009014N448Phase 3Completed
- Sponsor
- Hamadan University of Medical Sciences
- Start
- Dec 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of dexamethasone in None and Pollybeak deformity (2 arms), sponsored by Hamadan University of Medical Sciences. Primary endpoint: Improvement of supratip protrusion. Started Dec 2022; status: completed.
02
Drugs
dexamethasone
03
Conditions
Pollybeak deformity
Beyond the preview
Go deeper on IRCT20120215009014N448.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20120215009014N448.